Volitionrx (VNRX) Profit After Tax Growth (1y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.30% |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn | -9.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9.56% |
| Sep 30, 2025 | 7.07% |
| Jun 30, 2025 | 10.57% |
| Mar 31, 2025 | 35.36% |
| Dec 31, 2024 | 33.44% |
| Sep 30, 2024 | 31.13% |
| Jun 30, 2024 | 26.08% |
| Mar 31, 2024 | 4.52% |
| Dec 31, 2023 | -19.95% |
| Sep 30, 2023 | -8.20% |
| Jun 30, 2023 | -23.53% |
| Mar 31, 2023 | -14.96% |
| Dec 31, 2022 | 9.52% |
| Sep 30, 2022 | -8.78% |
| Jun 30, 2022 | -39.90% |
| Mar 31, 2022 | -26.00% |
| Dec 31, 2021 | -57.84% |
| Sep 30, 2021 | -65.94% |
| Jun 30, 2021 | -9.72% |
| Mar 31, 2021 | -4.71% |
| Dec 31, 2020 | -44.41% |
| Sep 30, 2020 | -3.52% |
| Jun 30, 2020 | -21.17% |
| Mar 31, 2020 | -39.16% |
| Dec 31, 2019 | 17.03% |
| Sep 30, 2019 | 6.61% |
| Jun 30, 2019 | 9.47% |
| Mar 31, 2019 | 9.64% |
| Jun 30, 2013 | -12.46% |
| Mar 31, 2013 | -13.23% |
| Dec 31, 2012 | -61.02% |
| Sep 30, 2012 | -21.92% |
| Jun 30, 2012 | -45.51% |
| Mar 31, 2012 | -139.21% |